Minnesota Gets Its First Psychedelic Medicine Clinic
The first psychedelic therapy clinic has opened in Minnesota. The Institute for Integrative Therapies will provide ketamine-assisted therapy.
The first psychedelic therapy clinic has opened in Minnesota. The Institute for Integrative Therapies will provide ketamine-assisted therapy.
Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).
Suggested guidances for use of ketamine and esketamine therapy have been published in the American Journal of Psychiatry.
This week in psychedelic business news sees pharmaceutical giant Merck enter the arena, psilocybin research, and more.
Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.
Rick Doblin, the founder of MAPS, joined actress Mayim Bialik’s podcast Breakdown to discuss MDMA and PTSD research.
The University of Wisconsin is the first in the U.S. to offer a master’s degree in development of psychedelic medicine.
Former presidential candidate Andrew Yang wants to decriminalize psilocybin. And if he becomes mayor of New York City, that could happen.
New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin.
Michigan could follow in the steps of Oregon to legalize psychedelics for therapeutic use. Ann Arbor already decriminalizes possession.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.